Allarity Therapeutics, Inc. (ALLR) vs Bionano Genomics, Inc. (BNGO)
A side-by-side comparison of Allarity Therapeutics, Inc. and Bionano Genomics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALLR
Allarity Therapeutics, Inc.
$1.00HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
BNGO
Bionano Genomics, Inc.
$1.45HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — ALLR vs BNGO
growth of $100 · dividends reinvested · last 5yALLR -100.0% (-95.9%/yr)BNGO -99.9% (-76.4%/yr)BNGO compounded faster over this window
Log scale — wide-divergence pair
ALLR BNGO
ALLR vs BNGO: by the numbers
- •BNGO is the larger company ($17M vs $16M market cap).
- •Both run net losses; BNGO's is the smaller (-106.58% vs -3575.07% net margin).
Metrics side by side
Valuation
| Metric | ALLR | BNGO |
|---|---|---|
| P/S ratio | 46.12 | 0.55 |
| P/B ratio | 4.50 | 0.52 |
Profitability
| Metric | ALLR | BNGO |
|---|---|---|
| Gross margin | 107.54% | 21.95% |
| Operating margin | -3939.06% | -116.95% |
| Net margin | -3575.07% | -106.58% |
| ROE | -348.81% | -101.76% |
| ROIC | -41.81% | -85.72% |
Growth (annualized)
| Metric | ALLR | BNGO |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 17.97% |
| Total return CAGR (5Y) | N/A | -78.37% |
Go deeper
Dig into the metrics
Allarity Therapeutics ROEBionano Genomics ROEAllarity Therapeutics operating marginBionano Genomics operating marginAllarity Therapeutics revenue growthBionano Genomics revenue growthAllarity Therapeutics free cash flowBionano Genomics free cash flow
Allarity Therapeutics & Bionano Genomics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.